MODIFICATION
A -- National Institute on Drug Abuse Center for Genetic Studies - Response to Questions
- Notice Date
- 6/5/2018
- Notice Type
- Modification/Amendment
- NAICS
- 541714
— Research and Development in Biotechnology (except Nanobiotechnology)
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse, 6001 Executive Boulevard, Room 4211, MSC 9559, Bethesda, Maryland, 20892-9559, United States
- ZIP Code
- 20892-9559
- Solicitation Number
- NIHDA201800084
- Archive Date
- 6/30/2018
- Point of Contact
- Joshua T. Lazarus, Phone: 3014436677, Andrew Hotaling, Phone: 301-443-6677
- E-Mail Address
-
josh.lazarus@nih.gov, andrew.hotaling@nih.gov
(josh.lazarus@nih.gov, andrew.hotaling@nih.gov)
- Small Business Set-Aside
- N/A
- Description
- The purpose of Amendment No. 1 is to amend the Request for Proposal (RFP) and to respond to formal questions submitted in response to the solicitation. All other terms and conditions of the RFP remain unchanged.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/NIDA-01/NIHDA201800084/listing.html)
- Place of Performance
- Address: Contractor's Facility, United States
- Record
- SN04944143-W 20180607/180605231134-6101d8d704215a02f040f823d61df1f5 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |